Study Name:
Liberty AIRED Study

Targeted Disease(s):
Asthma

Purpose of Study:

To Evaluate the Efficacy and Safety of Dupilumab in Participants with Allergic Bronchopulmonary Aspergillosis.

Study Dates:
September 15, 2020 - October 23, 2023

Study Design:
Controlled Design

Study Location:
Nationwide

Funding Source:
Regeneron Pharmaceuticals, Inc.

ClinicalTrails.gov Identifier:
NCT04442269

Contact:
Name: Clinical Trials Administrator
Phone: 844-734-6643
Email: [email protected]

 

Register for Trial
Freedom From Smoking Clinic
, | May 02, 2022
Freedom From Smoking Clinic
Virginia Beach, VA | May 10, 2022